Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT
• Segmentation by product
• Comparison by product
• Global vision care – Market size and forecast 2017-2022
• Global ophthalmology surgical devices – Market size and forecast 2017-2022
• Global ophthalmology diagnostic devices – Market size and forecast 2017-2022
• Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY END-USER
• Segmentation by end-user
• Hospitals and ophthalmology clinics
• Optical retail centers
• ASCs

PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 13: MARKET TRENDS
• Increasing number of strategic M&A
• Increasing number of partnerships
• Focus on promotional sales

PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive landscape

PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Carl Zeiss Meditec
• Essilor
• HOYA
• Johnson & Johnson
• NIDEK
• Novartis
• TOPCON
• Valeant Pharmaceuticals International
• Other prominent vendors

PART 16: APPENDIX
• List of abbreviations

[List of Exhibits]
Exhibit 01: Global medical devices market
Exhibit 02: Global medical devices market
Exhibit 03: Market characteristics
Exhibit 04: Global ophthalmology devices market segments
Exhibit 05: Global ophthalmology devices market definition – Inclusions and exclusions checklist
Exhibit 06: Global ophthalmology devices market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global ophthalmology devices market – Market size and forecast 2017-2022 ($ bn)
Exhibit 09: Global ophthalmology devices market– Year over year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2017
Exhibit 18: Product – Market share 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Global vision care – Market size and forecast 2017-2022 ($ bn)
Exhibit 21: Global vision care – Year over year growth 2018-2022 (%)
Exhibit 22: Global ophthalmology surgical devices – Market size and forecast 2017-2022 ($ bn)
Exhibit 23: Global ophthalmology surgical devices – Year over year growth 2018-2022 (%)
Exhibit 24: Global ophthalmology diagnostic devices – Market size and forecast 2017-2022 ($ bn)
Exhibit 25: Global ophthalmology diagnostic devices – Year over year growth 2018-2022 (%)
Exhibit 26: Market opportunity by product
Exhibit 27: Customer landscape
Exhibit 28: Global ophthalmology devices market by end-users (%) in 2017
Exhibit 29: Global ophthalmology devices market share by geography 2017-2022 (%)
Exhibit 30: Global ophthalmology devices market: Regional comparison
Exhibit 31: Americas – Market size and forecast 2017-2022 ($ bn)
Exhibit 32: Americas – Year over year growth 2018-2022 (%)
Exhibit 33: Top 3 countries in Americas
Exhibit 34: EMEA – Market size and forecast 2017-2022 ($ bn)
Exhibit 35: EMEA – Year over year growth 2018-2022 (%)
Exhibit 36: Top 3 countries in EMEA
Exhibit 37: APAC – Market size and forecast 2017-2022 ($ bn)
Exhibit 38: APAC – Year over year growth 2018-2022 (%)
Exhibit 39: Top 3 countries in APAC
Exhibit 40: Global ophthalmology devices market opportunity
Exhibit 41: Market impact analysis: Increasing number of eye diseases in few regions
Exhibit 42: Market impact analysis: Product launches
Exhibit 43: Market impact analysis: Strategic M&A
Exhibit 44: Market impact: Upcoming M&A
Exhibit 45: Vendor landscape
Exhibit 46: Landscape disruption
Exhibit 47: Competitive structure analysis of global ophthalmology devices market 2017
Exhibit 48: Vendors covered
Exhibit 49: Vendor classification
Exhibit 50: Market positioning of vendors
Exhibit 51: Carl Zeiss Meditec – Overview
Exhibit 52: Carl Zeiss Meditec: Business segments
Exhibit 53: Carl Zeiss Meditec: Organizational developments
Exhibit 54: Carl Zeiss Meditec: Geographic focus
Exhibit 55: Carl Zeiss Meditec: Segment focus
Exhibit 56: Carl Zeiss Meditec: Key offerings
Exhibit 57: Carl Zeiss Meditec: Key customers
Exhibit 58: Essilor: Overview
Exhibit 59: Essilor: Business segments
Exhibit 60: Essilor: Organizational developments
Exhibit 61: Essilor: Geographic focus
Exhibit 62: Essilor: Segment focus
Exhibit 63: Essilor: Key offerings
Exhibit 64: Essilor: Key customers
Exhibit 65: HOYA: overview
Exhibit 66: HOYA: Business segments
Exhibit 67: HOYA– Organizational developments
Exhibit 68: HOYA – Geographic focus
Exhibit 69: HOYA – Segment focus
Exhibit 70: HOYA: Key offerings
Exhibit 71: HOYA: Key customers
Exhibit 72: Johnson & Johnson: Overview
Exhibit 73: Johnson & Johnson: Business segments
Exhibit 74: Johnson & Johnson: Organizational developments
Exhibit 75: Johnson & Johnson: Geographic focus
Exhibit 76: Johnson & Johnson: Segment focus
Exhibit 77: Johnson & Johnson: Key offerings
Exhibit 78: Johnson & Johnson: Key customers
Exhibit 79: NIDEK: Overview
Exhibit 80: NIDEK: Business segments
Exhibit 81: NIDEK: Organizational developments
Exhibit 82: NIDEK – Geographic focus
Exhibit 83: NIDEK – Segment focus
Exhibit 84: NIDEK: Key offerings
Exhibit 85: NIDEK: Key customers
Exhibit 86: Novartis: Overview
Exhibit 87: Novartis: Business segments
Exhibit 88: Novartis: Organizational developments
Exhibit 89: Novartis: Geographic focus
Exhibit 90: Novartis: Segment focus
Exhibit 91: Novartis: Key offerings
Exhibit 92: Novartis: Key customers
Exhibit 93: TOPCON – Overview
Exhibit 94: TOPCON: Business segments
Exhibit 95: TOPCON: Organizational developments
Exhibit 96: TOPCON – Geographic focus
Exhibit 97: TOPCON – Segment focus
Exhibit 98: TOPCON: Key offerings
Exhibit 99: TOPCON: Key customers
Exhibit 100: Valeant Pharmaceuticals International overview
Exhibit 101: Valeant Pharmaceuticals International: Business segments
Exhibit 102: Valeant Pharmaceuticals International – Organizational developments
Exhibit 103: Valeant Pharmaceuticals International – Geographic focus
Exhibit 104: Valeant Pharmaceuticals International – Segment focus
Exhibit 105: Valeant Pharmaceuticals International: Key offerings
Exhibit 106: Valeant Pharmaceuticals International: Key customers